CP-61,405, a novel polycyclic pyrrolether antibiotic produced byStreptomyces routienii Huang sp. nov. |
| |
Authors: | Walter P. Cullen Walter D. Celmer Larry R. Chappel Liang H. Huang Mark T. Jefferson Masaru Ishiguro Hiroshi Maeda Satoshi Nishiyama John R. Oscarson Riichiro Shibakawa Junsuke Tone |
| |
Affiliation: | (1) Central Research, Pfizer Inc., 06340 Nagoya, Japan;(2) Central Research, Pfizer Inc., 06340 Groton, CT, U.S.A. |
| |
Abstract: | Summary CP-61,405 (C26H29N2O7Na) is a novel polycyclic pyrrolether antibiotic produced by a new species,Streptomyces routienii Huang sp. nov. (ATCC 39446). Recovery, fractionation and purification were achieved using standard procedures. The crystalline form includes the CP-61,405 sodium salt, m.p. 334–335°C, []D25°C+315°C (c=1, chloroform). The structure is shown below. CP-61,405 was co-produced with the polycyclic ether antibiotics salinomycin and epi-17-deoxy-(0–8)-salinomycin. It exhibited activity in vitro against gram-positive and anaerobic bacteria, efficacy against poultry coccidia and stimulation in vitro of propionic acid production. |
| |
Keywords: | CP-61,405 Pyrrolether Streptomyces routienii Huang sp. nov. Anticoccidial agent |
本文献已被 SpringerLink 等数据库收录! |
|